Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 5
2006 1
2007 6
2008 15
2009 6
2010 11
2011 19
2012 20
2013 27
2014 39
2015 41
2016 32
2017 53
2018 64
2019 56
2020 45
2021 25
Text availability
Article attribute
Article type
Publication date

Search Results

420 results
Results by year
Filters applied: . Clear all
Page 1
An Online Intervention Comparing a Very Low-Carbohydrate Ketogenic Diet and Lifestyle Recommendations Versus a Plate Method Diet in Overweight Individuals With Type 2 Diabetes: A Randomized Controlled Trial.
Saslow LR, Mason AE, Kim S, Goldman V, Ploutz-Snyder R, Bayandorian H, Daubenmier J, Hecht FM, Moskowitz JT. Saslow LR, et al. J Med Internet Res. 2017 Feb 13;19(2):e36. doi: 10.2196/jmir.5806. J Med Internet Res. 2017. PMID: 28193599 Free PMC article. Clinical Trial.
OBJECTIVE: The aim was to determine whether an online intervention based on our previous recommendations (an ad libitum very low-carbohydrate ketogenic diet with lifestyle factors; "intervention") or an online diet program based on the American Diabetes
OBJECTIVE: The aim was to determine whether an online intervention based on our previous recommendations (an ad libitum very low-carb …
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention.
Hostalek U, Gwilt M, Hildemann S. Hostalek U, et al. Drugs. 2015 Jul;75(10):1071-94. doi: 10.1007/s40265-015-0416-8. Drugs. 2015. PMID: 26059289 Free PMC article. Review.
Lifestyle interventions aimed at inducing weight loss, pharmacologic treatments (metformin, thiazolidinediones, acarbose, basal insulin and drugs for weight loss) and bariatric surgery have all been shown to reduce the risk of progression to type 2 …
Lifestyle interventions aimed at inducing weight loss, pharmacologic treatments (metformin, thiazolidinediones, acarbose, basa …
Dietary Interventions for the Prevention of Type 2 Diabetes in High-Risk Groups: Current State of Evidence and Future Research Needs.
Guess ND. Guess ND. Nutrients. 2018 Sep 6;10(9):1245. doi: 10.3390/nu10091245. Nutrients. 2018. PMID: 30200572 Free PMC article. Review.
Weight loss appears to be the primary driver of type 2 diabetes risk reduction, with individual dietary components playing a minor role. ...The limited data available question whether moderate weight loss is effective at preventing type 2 dia
Weight loss appears to be the primary driver of type 2 diabetes risk reduction, with individual dietary components play
Diet and exercise in the prevention and treatment of type 2 diabetes mellitus.
Magkos F, Hjorth MF, Astrup A. Magkos F, et al. Nat Rev Endocrinol. 2020 Oct;16(10):545-555. doi: 10.1038/s41574-020-0381-5. Epub 2020 Jul 20. Nat Rev Endocrinol. 2020. PMID: 32690918 Review.
Evidence from observational studies and randomized trials suggests that prediabetes and type 2 diabetes mellitus (T2DM) can develop in genetically susceptible individuals in parallel with weight (that is, fat) gain. Accordingly, studies show that weight
Evidence from observational studies and randomized trials suggests that prediabetes and type 2 diabetes mellitus (T2DM) can de …
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group. Pi-Sunyer X, et al. N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892. N Engl J Med. 2015. PMID: 26132939 Free article. Clinical Trial.
BACKGROUND: Obesity is a chronic disease with serious health consequences, but weight loss is difficult to maintain through lifestyle intervention alone. ...RESULTS: At baseline, the mean (SD) age of the patients was 45.112.0 years, the mean weight was …
BACKGROUND: Obesity is a chronic disease with serious health consequences, but weight loss is difficult to maintain through li …
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group. le Roux CW, et al. Lancet. 2017 Apr 8;389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7. Epub 2017 Feb 23. Lancet. 2017. PMID: 28237263 Clinical Trial.
Liraglutide induced greater weight loss than placebo at week 160 (-61 [SD 73] vs -19% [63]; estimated treatment difference -43%, 95% CI -49 to -37, p<00001). ...Liraglutide 30 mg might provide health benefits in terms of reduced risk of diabetes in individ …
Liraglutide induced greater weight loss than placebo at week 160 (-61 [SD 73] vs -19% [63]; estimated treatment difference -43 …
The prevention of type 2 diabetes.
Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, Haffner SM, Hoskin M, Nathan DM; Diabetes Prevention Program Research Group. Crandall JP, et al. Nat Clin Pract Endocrinol Metab. 2008 Jul;4(7):382-93. doi: 10.1038/ncpendmet0843. Epub 2008 May 20. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18493227 Free PMC article. Review.
In prediabetic states insulin secretion and action--potential targets of preventive interventions--are impaired. In trials lifestyle modification (i.e. weight loss and exercise) has proven effective in preventing incident T2DM in high-risk groups, although weight
In prediabetic states insulin secretion and action--potential targets of preventive interventions--are impaired. In trials lifestyle modific …
Global Diabetes Prevention Interventions: A Systematic Review and Network Meta-analysis of the Real-World Impact on Incidence, Weight, and Glucose.
Galaviz KI, Weber MB, Straus A, Haw JS, Narayan KMV, Ali MK. Galaviz KI, et al. Diabetes Care. 2018 Jul;41(7):1526-1534. doi: 10.2337/dc17-2222. Diabetes Care. 2018. PMID: 29934481 Free PMC article. Review.
Effectiveness/translation studies of any design testing LSM strategies, targeting high-risk populations (with prediabetes or diabetes risk factors), and reporting diabetes incidence, weight, or glucose outcomes were included. ...Every additional kilogr …
Effectiveness/translation studies of any design testing LSM strategies, targeting high-risk populations (with prediabetes or diabe
Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force.
LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. LeBlanc EL, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. PMID: 30354042 Free Books & Documents. Review.
2) Do primary care-relevant behavioral and/or pharmacotherapy weight loss and weight loss maintenance interventions lead to weight loss, weight loss maintenance, or a reduction in the incidence or prevalence of obesity-relat …
2) Do primary care-relevant behavioral and/or pharmacotherapy weight loss and weight loss maintenance interventi …
Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial.
Salas-Salvadó J, Díaz-López A, Ruiz-Canela M, Basora J, Fitó M, Corella D, Serra-Majem L, Wärnberg J, Romaguera D, Estruch R, Vidal J, Martínez JA, Arós F, Vázquez C, Ros E, Vioque J, López-Miranda J, Bueno-Cavanillas A, Tur JA, Tinahones FJ, Martín V, Lapetra J, Pintó X, Daimiel L, Delgado-Rodríguez M, Matía P, Gómez-Gracia E, Díez-Espino J, Babio N, Castañer O, Sorlí JV, Fiol M, Zulet MÁ, Bulló M, Goday A, Martínez-González MÁ; PREDIMED-Plus investigators. Salas-Salvadó J, et al. Diabetes Care. 2019 May;42(5):777-788. doi: 10.2337/dc18-0836. Epub 2018 Nov 2. Diabetes Care. 2019. PMID: 30389673 Clinical Trial.
OBJECTIVE: The long-term impact of intentional weight loss on cardiovascular events remains unknown. We describe 12-month changes in body weight and cardiovascular risk factors in PREvencion con DIeta MEDiterranea (PREDIMED)-Plus, a trial designed to evaluate …
OBJECTIVE: The long-term impact of intentional weight loss on cardiovascular events remains unknown. We describe 12-month chan …
420 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page